Stockscreener 앱 받기
0.3669
0.03%
0.000100
시장 영업 전:
.38
0.0131
+3.57%
전일 마감가:
$0.3668
열려 있는:
$0.35
하루 거래량:
88,984
Relative Volume:
0.25
시가총액:
$10.40M
수익:
-
순이익/손실:
$-435.00K
주가수익비율:
-23.37
EPS:
-0.0157
순현금흐름:
$-665.30K
1주 성능:
+10.98%
1개월 성능:
-15.66%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.35
$0.385
1주일 범위
$0.33
$0.39
52주 변동 폭
$0.322
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
명칭
Curanex Pharmaceuticals Inc
전화
718-673-6078
주소
2 JERICHO PLAZA,, JERICHO
CURX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.3669 | 10.40M | 0 | -435.00K | -665.30K | -0.0157 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Curanex Pharmaceuticals Inc 주식(CURX)의 최신 뉴스
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Canada
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Inc Announces Chief Financial Officer Changes - MarketScreener
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to S&P TMI Index - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Weekly Research Analysts’ Ratings Updates for Curanex Pharmaceuticals (CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) is looking forward to a strong quarter - setenews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Curanex Pharmaceuticals Faces Nasdaq Delisting Warning - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Wall Street Zen Downgrades Curanex Pharmaceuticals (NASDAQ:CURX) to Sell - Defense World
Curanex Pharmaceuticals Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
Curanex Pharmaceuticals Inc SEC 10-Q Report - TradingView
Curanex Pharmaceuticals receives Nasdaq notice on minimum bid price requirement - Investing.com India
Curanex Pharmaceuticals IncCommon Stock (NQ: CURX - FinancialContent
Curanex engages Strategic Investor Relations to enhance Curanex’s visibility - MSN
Curanex Pharmaceuticals (CURX): An Emerging Force in US Botanical Drug Development - Markets Financial Content
Curanex Pharmaceuticals (CURX): An Emerging Force In US Botanical Drug Development - Menafn.com
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement - The Manila Times
Curanex Pharmaceuticals Inc. Engages Strategic Investor - GlobeNewswire
Curanex (Nasdaq: CURX) engages Strategic Investor Relations; UC lead IND targeted in 2026 - Stock Titan
Price performance - Yahoo
Curanex Pharmaceuticals Inc (CURX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):